Loading clinical trials...
Loading clinical trials...
The overall objective of this study is to assess the feasibility and potential impact of using a targeted testing approach and 2 interferon-gamma release assays (IGRA) to screen for latent tuberculosi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Henry M. Jackson Foundation for the Advancement of Military Medicine
Collaborators
NCT06033807 · Tuberculosis, Latent Tuberculosis Infection
NCT05746611 · Latent Tuberculosis Infection
NCT02641106 · Tuberculosis, Latent Tuberculosis Infection
NCT01622140 · Latent Tuberculosis Infection, Tuberculosis
NCT02810678 · Latent Tuberculosis Infection
Fort Jackson, SC
Columbia, South Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions